NCT00084812View on ClinicalTrials.gov

Safingol and Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

cisplatin

DRUG

safingol

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00084812 - Safingol and Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors | Biotech Hunter | Biotech Hunter